Alere Flu Test Wins First CLIA Waiver For Nucleic Acid Assay
This article was originally published in The Gray Sheet
Executive Summary
Alere’s i Influenza A & B test was granted a CLIA waiver Jan. 6, a step toward moving traditionally complex molecular diagnostics to a wider array of testing settings.